STRATA Skin Sciences Inc. (SSKN): Enterprise Value to EBITDA Ratio
This daily price chart for STRATA Skin Sciences (SSKN) shows a value of 0.00. STRATA Skin Sciences sources emitter components externally while maintaining control over the software and delivery. The assembly of dermatological laser devices takes place in the US, with profits driven by recurring payments from clinics. The growth strategy relies on targeted partnerships with medical centers to achieve organic growth in the number of procedures.
Comprehensive metric breakdowns and analytics for strataskinsciences.com (SSKN)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio STRATA Skin Sciences|SSKN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity STRATA Skin Sciences, Inc.|SSKN - Company Total Debt|Debts to Book Capitalization STRATA Skin Sciences, Inc.|SSKN - Long-Term Debt|Company Short-Term Debts STRATA Skin Sciences|Quick Ratio strataskinsciences.com
- financial results and valuation multiples details:
SSKN - Net Financial Result|Projected Future Earnings STRATA Skin Sciences|SSKN - Price to Earnings Ratio|Forward P/E Multiple STRATA Skin Sciences, Inc.|SSKN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences, Inc.|SSKN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months STRATA Skin Sciences|SSKN - Earnings per share for the trailing year|Quarterly EPS earnings growth strataskinsciences.com|SSKN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year STRATA Skin Sciences
Analysis of all company metrics:STRATA Skin SSKN
The steady stream of recurring payments for the maintenance of STRATA Skin Sciences (SSKN) laser systems requires a precise valuation of the business relative to its operating profit. The company's dynamic EV/EBITDA ratio compares the total enterprise value, including net debt, with earnings before interest, taxes, depreciation, and amortization, neutralizing the impact of accounting policies. Analysis of this chart allows investors to filter out market noise and determine the asset's actual investment attractiveness.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio KNW|NARI (Inari Medical Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|RSLS (reshapelifesciences.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SILK (Silk Road Medical, Inc)
